Page URL:

Nuffield launches 'personalised healthcare' report

18 October 2010
Appeared in BioNews 580

The UK's Nuffield Council on Bioethics has reported that direct-to-consumer personal genetic profiling services used to predict people's genetic susceptibility for common diseases, such as Parkinson's and diabetes, are often inconclusive, misleading and can potentially cause unnecessary anxiety, complacency or distress when no treatment is available. The potential harms did not justify restricting sales, except to prohibit the genetic profiling of children.

The report warned of largely unregulated businesses trying to capitalise on the promise of 'personalised medicine' through offering online healthcare information and services. Health and advertising regulators should request companies provide evidence to support claims and provide public warnings about tests' predictive value and insurance implications, it suggested. The report concluded the Government should do more to train its healthcare providers and to educate the public on how to use online health services safely and effectively.

The Chair, Professor Christopher Hood of Oxford University, explained: 'What we want to do in general, is neither to ban these developments nor to make them compulsory, but to find ways of helping people to use them more effectively and to provide protections where those are needed'.

The Nuffield Council on Bioethics, an independent body established to examine ethical issues in biology and medicine, looked broadly at direct-to-consumer testing and ways of accessing online healthcare information, the purchase of medicines and record keeping.

The Working Group recognised that online health services could bring significant benefits by increasing convenience and choice, empowering individuals to better manage their health and seek earlier or preventative treatment without accessing public resources. It warned, however, of significant risks when bypassing physician involvement.

The report followed a two-year inquiry and was published on 12 October 2010.

Personalised healthcare
Nuffield Council |  12 October 2010
12 December 2011 - by Mehmet Fidanboylu 
The National Institutes of Health (NIH) in the US has demonstrated its intent to make personalised medicine a reality by outlining plans for projects set to cost almost half a billion US dollars...
8 August 2011 - by Dr Rebecca Hill 
'The age of personalised medicine: genes, privacy and discrimination?' was the last in BioCentre's 2010/2011 symposium series 'Revolution, Regulation and Responsibilities', and promised to 'appraise current developments and consider the current legal and regulatory position for their use before taking time to reflect and assess the future impact on society'...
8 August 2011 - by Dr Kimberley Bryon-Dodd 
The NHS is 'unprepared' to deal with personalised medicine in the clinic, according to Sir John Bell - the UK Government's chief genetics advisor - during an interview with the Times. His comments come as a four-year-old girl last week became Britain's first person to have a rare genetic disease identified through DNA sequencing...
6 June 2011 - by Rosemary Paxman 
Direct-to-consumer (DTC) genetic tests provide an inaccurate prediction of disease risk and offer little benefit to consumers, scientists claim...
11 April 2011 - by Ben Jones 
The Nuffield Council on Bioethics has begun a broad project exploring how legislators and members of the public respond to emerging biotechnologies. Calling for opinions and evidence, the Council has begun a preliminary consultation that seeks to identify common social, ethical, legal and policy issues raised by biotechnological developments...
27 April 2009 - by Ben Jones 
The UK's Nuffield Council on Bioethics, an independent group of experts, is launching a new inquiry into the growing - and largely unregulated - provision of medical services through the internet and by consumer-targeted businesses. The multi-disciplinary group of experts will look at patients' experience of services including DNA...
22 September 2005 - by BioNews 
The UK's Royal Society has published a report on the potential of pharmacogenetics - drug treatments tailored to a person's genetic make-up - following a year-long investigation into the subject. It concludes that although 'personalised medicines' have a promising future, it will be at least another 15-20 years before their use...
25 November 2002 - by BioNews 
The UK's Nuffield Council on Bioethics has launched a public consultation on the ethical issues raised by the future development of medical prescriptions tailored to a person's genetic make-up. The paper, published on 19 November, poses twenty questions relating to the use of genetic tests to predict how a person...
25 November 2002 - by Dr Jess Buxton 
Last week saw the launch of a public consultation on the ethics of pharmacogenetics Ð the use of genetic tests to decide on the safest and most effective medicines for an individual. In years to come, such tailored treatments may be a routine part of healthcare, with your doctor checking out...
7 October 2002 - by BioNews 
The UK's Nuffield Council on Bioethics has published a report on the ethical, legal and social issues that are raised by behavioural genetics research. The report is called 'Genetics and human behaviour: the ethical context'. One recommendation that the Council highlights is that it should not be permissible to use...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.